Faculty Opinions recommendation of Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

2013 ◽  
Author(s):  
J Michael Kilby
Keyword(s):  
Hiv Infection ◽  
Drug Users ◽  
Injecting Drug Users ◽  
Phase 3 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Antiretroviral Prophylaxis

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

The Lancet ◽  
2013 ◽  
Vol 381 (9883) ◽  
pp. 2083-2090 ◽  
Author(s):  
Kachit Choopanya ◽  
Michael Martin ◽  
Pravan Suntharasamai ◽  
Udomsak Sangkum ◽  
Philip A Mock ◽  
...  
Keyword(s):  
Hiv Infection ◽  
Drug Users ◽  
Injecting Drug Users ◽  
Phase 3 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Antiretroviral Prophylaxis

Double blind placebo controlled clinical trial of homoeopathic medicines in HIV infection

1998 ◽  
Vol 87 (2) ◽  
pp. 86-88
Author(s):  
D P Rastogi ◽  
V P Singh ◽  
Vikram Singh ◽  
S K Dey ◽  
K Rao
Keyword(s):  
Clinical Trial ◽  
Hiv Infection ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Double Blind Placebo

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

2018 ◽  
Author(s):  
Tilman Polster ◽  
Lieven Lagae ◽  
Joseph Sullivan ◽  
Ulrich Brandl ◽  
Arne Herting ◽  
...  
Keyword(s):  
Controlled Trial ◽  
Phase 3 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
First Results
Sign in / Sign up

Export Citation Format

Share Document